Affiliation:
1. Moscow Municipal Scientific Practical Center of Tuberculosis Control, Moscow Health Department; Russian Medical Academy of On-going Professional Education, Russian Ministry of Health
2. Moscow Municipal Scientific Practical Center of Tuberculosis Control, Moscow Health Department
Abstract
The objective: to evaluate the effectiveness of screening for tuberculosis infection in risk groups among adults using the skin test with tuberculous recombinant allergen (TRA) - Diaskintest®.Subjects and Methods. In 2019-2021, screening for tuberculosis infection in risk groups and in the population with an unknown risk was carried out covering 449,842 people. People aged 18 years and older were examined - patients of the Tuberculosis Control Center, polyclinics and hospitals of medical organizations of the Moscow Health Department. Questionable results were taken into account as positive results of the TRA test.Results. The frequency of positive results of the TRA test in healthy population was as follows: in those contacting pregnant women and newborns - 2.0% (95% CI 1,54-2,10); in decreed groups (workers in food industry, water supply organizations, utilities) - 2,68% (95% CI 2,54-2,82). The situation was different in social risk groups (foreign citizens and stateless persons) - they responded positively to the TRA test in 21,05% (95% CI 20,08-22,06). Most of them arrived to Moscow from states with a high burden of tuberculosis. High-risk groups also include those abusing alcohol and substances; they had positive results in 10,58% (95% CI 8,41-13,24). Among the medical risk groups, the highest rates were observed in those followed up by tuberculosis control services after tuberculosis treatment completion - 39,96% (95% CI 38,31-41,64).Conclusion. Screening in the groups facing the highest risk of developing tuberculosis had a positive effect and once again confirmed the need to screen both resident and migrating population. The immunological skin test with Diaskintest is a reliable tool for examining tuberculosis risk groups.
Publisher
LLC "Medical Knowledge and Technologies"
Reference25 articles.
1. Aksenova V. A., Baryshnikova L. A., Dolzhenko E. N., Kudlay D. A. Topical issues of mass screening in children for tuberculosis under current conditions. Doktor.Ru, 2012, no. 8 (76), pp. 27-29. (In Russ.)
2. Aksenova V. A., Vasilyeva I. A., Klevno N. I., Kazakov A. V., Doktorova N. P. Validity of a negative skin test result with recombinant tuberculosis allergen in order to exclude the active tuberculosis in children. Pediatriya im. G. N. Speranskogo, 2022, vol. 101, no. 4, pp. 43-49. (In Russ.) https://www.doi.org/10.24110/0031-403X-2022-101-4-43-49
3. Aksenova V. A., Gordina A. V., Sterlikov S. A., Kudlay D. A., Kucheryavaya D. A., Doktorova N. P. Impact of active case finding on clinical structure and severity of tuberculosis in school-aged children (7-15 years old). Tuberculosis and Lung Diseases, 2022, vol. 100, no. 1, pp. 26-32. (In Russ.) http://doi.org/10.21292/2075-1230-2022-100-1-26-32
4. Kiselev V. I., Baranovskiy P. M., Pupyshev S. A. et al. The new skin test for tuberculosis diagnostics based on recombinant protein of ESAT-CFP. Molekulyarnaya Meditsina, 2008, no. 4, pp. 4-6. (In Russ.)
5. Litvinov V. I., Slogotskaya L. V., Seltsovskiy P. P. et al. The new skin test for tuberculous infection diagnostics. Rossiyskiy Meditsinskiy Journal, 2009, no. 1, pp. 52-56. (In Russ.)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献